C Marc Leyrer
Overview
Explore the profile of C Marc Leyrer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
341
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farris J, Hughes R, Razavian N, Pearce J, Snavely A, Chan M, et al.
Adv Radiat Oncol
. 2023 Jun;
8(3):101058.
PMID: 37273925
Purpose: Brain metastases (BMs) are a common source of morbidity and mortality. Guidelines do not advise brain surveillance for locally advanced non-small cell lung cancer (LA-NSCLC). We describe the incidence,...
2.
Steber C, Hughes R, Soike M, Helis C, Nieto K, Jacobson T, et al.
Acta Oncol
. 2021 Mar;
60(5):605-612.
PMID: 33645424
Introduction: In patients with non-small cell lung cancer (NSCLC) who present with multiple pulmonary nodules, it is often difficult to distinguish metastatic disease from synchronous primary lung cancers (SPLC). We...
3.
Tom M, Park D, Yang K, Leyrer C, Wei W, Jia X, et al.
Int J Radiat Oncol Biol Phys
. 2019 Aug;
105(5):1106-1112.
PMID: 31461674
Purpose: Malignant transformation (MT) of adult grade 2 glioma (low-grade glioma [LGG]) is associated with adverse survival. We sought to describe the incidence, outcomes, and risk factors for MT of...
4.
Tom M, Varra V, Leyrer C, Park D, Chao S, Yu J, et al.
Int J Radiat Oncol Biol Phys
. 2019 Apr;
104(5):1099-1105.
PMID: 31022510
Purpose: To identify risk factors for progression-free survival (PFS) in the molecular era among patients with low-grade glioma (LGG) who undergo gross total resection (GTR) followed by initial observation. Methods...
5.
Morgan S, Hoffman K, Loblaw D, Buyyounouski M, Patton C, Barocas D, et al.
J Urol
. 2019 Feb;
201(3):528-534.
PMID: 30759696
Purpose: The aim of this guideline is to present recommendations regarding moderately hypofractionated (240-340 cGy per fraction) and ultrahypofractionated (500 cGy or more per fraction) radiation therapy for localized prostate...
6.
Morgan S, Hoffman K, Loblaw D, Buyyounouski M, Patton C, Barocas D, et al.
Pract Radiat Oncol
. 2018 Oct;
8(6):354-360.
PMID: 30322661
Purpose: The aim of this guideline is to present recommendations regarding moderately hypofractionated (240-340 cGy per fraction) and ultrahypofractionated (500 cGy or more per fraction) radiation therapy for localized prostate...
7.
Morgan S, Hoffman K, Loblaw D, Buyyounouski M, Patton C, Barocas D, et al.
J Clin Oncol
. 2018 Oct;
:JCO1801097.
PMID: 30307776
No abstract available.
8.
Leyrer C, Berriochoa C, Agrawal S, Donaldson A, Calhoun B, Shah C, et al.
Breast Cancer Res Treat
. 2017 Jul;
165(3):499-504.
PMID: 28689362
Purpose: Metaplastic breast cancer (MBC) is a rare, aggressive variant of breast cancer, with limited data available regarding treatment and outcomes. This study aims to review patients with MBC treated...
9.
Leyrer C, Chan M, Peiffer A, Horne E, Harmon M, Carter A, et al.
Pract Radiat Oncol
. 2014 Jun;
4(2):130-135.
PMID: 24890354
Purpose: Radiation-induced taste and smell disturbances are prevalent in patients receiving brain radiation therapy, although the mechanisms underlying these toxicities are poorly understood. We report the results of a single...
10.
Peiffer A, Leyrer C, Greene-Schloesser D, Shing E, Kearns W, Hinson W, et al.
Neurology
. 2013 Feb;
80(8):747-53.
PMID: 23390169
Objective: In a retrospective review to assess neuroanatomical targets of radiation-induced cognitive decline, dose volume histogram (DVH) analyses of specific brain regions of interest (ROI) are correlated to neurocognitive performance...